![Sunny Reddy](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profile
Sunny joined Aisling in 2019 and serves as a Principal.
Prior to Aisling, Sunny was an Associate and Analyst at SVB Leerink, a healthcare-specialist investment bank, focusing on biopharma/therapeutics.
Prior to SVB Leerink, Sunny was a Quantitative Analyst at Bank of America Merrill Lynch specializing in credit derivative products.
He was also a research associate working in oncology drug development prior to his careers in finance and investing.
Sunny currently serves as a board observer for Forge Biologics, Garuda Therapeutics and Wugen.
His prior board service includes Monte Rosa Therapeutics (observer).
Sunny received his B.S.
in Biomedical Engineering from the Georgia Institute of Technology with high honors and was a HOPE and Zell Miller Scholar recipient.
Sunny Reddy active positions
| Companies | Position | Start |
|---|---|---|
Aisling Capital LLC
 Aisling Capital LLC Investment ManagersFinance Aisling Capital invests in both private and public companies located in the Unites States. The firm targets companies operating in the fields of developing & commercializing important and innovative healthcare products, services & technologies sectors and industries. It provides financing for royalty deals, large cap leveraged buyout, seed, early and late stage capital requirements in the form of equity and debt. | Private Equity Investor | 2019-08-31 |
Training of Sunny Reddy
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
15
1st degree connections
2
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
Aisling Capital LLC
Aisling Capital LLC Investment ManagersFinance Aisling Capital invests in both private and public companies located in the Unites States. The firm targets companies operating in the fields of developing & commercializing important and innovative healthcare products, services & technologies sectors and industries. It provides financing for royalty deals, large cap leveraged buyout, seed, early and late stage capital requirements in the form of equity and debt. | Finance |
Georgia Institute of Technology
 Georgia Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
- Stock Market
- Insiders
- Sunny Reddy
